Blue Fin Vision® Featured in Metro: FOXC1 and Lifelong Eye Monitoring
- Posted
- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Chris Dunnington
- Published: August 12, 2026
- Last Updated: August 12, 2026
TL;DR: Mr Mfazo Hove, consultant ophthalmic surgeon and founder of Blue Fin Vision®, provided expert comment to Metro on the story of Violet Paul, a one-year-old born with a FOXC1 gene variant who has begun to see for the first time after trabeculotomy surgery. His message is that genetic risk is not a prognosis, provided the right monitoring is in place.
Expert Comment on a Rare Genetic Condition
Violet was born with no irises, raised eye pressure and jittery eye movement, and celebrated her first birthday watching fireworks her doctors thought she would never see. Explaining the wider picture, Mr Hove told Metro that FOXC1 variants can cause photophobia, or light sensitivity, along with reduced vision and glare.
He added that with regular monitoring, modern glaucoma treatments and appropriate visual rehabilitation, many people retain useful vision throughout their lives.
Why Monitoring Changes the Outcome
Mr Hove’s closing point to Metro reflects the principle behind structured follow-up at Blue Fin Vision®: “Genes like FOXC1 don’t determine someone’s future, but they do tell us who needs careful lifelong monitoring so we can protect vision before damage occurs.”
That distinction matters in glaucoma in particular, where raised pressure damages the optic nerve silently and any sight already lost cannot be restored. Identifying who needs watching, and then actually watching them, is what preserves vision.
Read the Full Coverage
Metro: Moment baby born blind sees city lights for first time after eye surgery, published 5 August 2026.
Worried About Eye Pressure or a Family History?
If glaucoma runs in your family, or you have been told your eye pressure is raised, the Blue Fin Vision® team invites you to book a consultation to discuss monitoring and treatment at our consultant-led clinics across London, Hertfordshire and Essex.
